Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atrion Co. stock logo
ATRI
Atrion
$459.92
$459.06
$274.98
$503.24
$809.46M0.6923,283 shsN/A
Axonics, Inc. stock logo
AXNX
Axonics
$70.98
$70.61
$67.27
$71.05
$3.63B0.82423,430 shsN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$27.49
$27.31
$6.08
$27.51
$1.12B1.531.20 million shsN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$334.75
$332.85
$157.00
$334.90
$12.57B0.88968,088 shsN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$10.35
+2.2%
$10.49
$8.61
$21.10
$235.50M0.95256,112 shs124,870 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atrion Co. stock logo
ATRI
Atrion
0.00%0.00%0.00%0.00%+1.20%
Axonics, Inc. stock logo
AXNX
Axonics
0.00%0.00%0.00%0.00%+5.12%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.00%0.00%0.00%0.00%+1.81%
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.00%0.00%0.00%0.00%0.00%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.00%+0.10%+2.37%-21.53%-9.45%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atrion Co. stock logo
ATRI
Atrion
N/AN/AN/AN/AN/AN/AN/AN/A
Axonics, Inc. stock logo
AXNX
Axonics
N/AN/AN/AN/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.4016 of 5 stars
0.80.00.04.30.00.00.6
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
N/AN/AN/AN/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
3.1039 of 5 stars
3.01.00.00.01.12.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atrion Co. stock logo
ATRI
Atrion
0.00
N/AN/AN/A
Axonics, Inc. stock logo
AXNX
Axonics
2.00
HoldN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
1.50
Reduce$27.500.04% Upside
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.00
N/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.00
Hold$16.0054.59% Upside

Current Analyst Ratings Breakdown

Latest SILK, AXNX, ATRI, SWAV, and TCMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/6/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$25.00 ➝ $14.00
(Data available from 7/6/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atrion Co. stock logo
ATRI
Atrion
$181.60M4.46$19.68 per share23.37$138.02 per share3.33
Axonics, Inc. stock logo
AXNX
Axonics
$366.38M9.90$0.13 per share561.96$12.59 per share5.64
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
$177.13M6.31N/AN/A$3.88 per share7.09
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$787.97M15.95$4.31 per share77.61$20.02 per share16.72
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$293.16M0.82$1.11 per share9.36$9.03 per share1.15
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atrion Co. stock logo
ATRI
Atrion
$19.41M$10.6443.23N/A10.60%7.75%7.12%N/A
Axonics, Inc. stock logo
AXNX
Axonics
-$6.09M-$0.12N/A80.66N/A-1.31%0.36%0.31%N/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
-$55.74M-$1.37N/AN/AN/A-29.53%-37.30%-21.57%N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
$147.28M$4.2878.2154.342.4320.75%24.79%11.95%N/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$16.96M$0.6615.6812.32N/A5.52%8.41%6.10%8/4/2025 (Estimated)

Latest SILK, AXNX, ATRI, SWAV, and TCMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/5/2025Q1 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atrion Co. stock logo
ATRI
Atrion
$8.801.91%N/A82.71%21 Years
Axonics, Inc. stock logo
AXNX
Axonics
N/AN/AN/AN/AN/A
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/AN/AN/AN/AN/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atrion Co. stock logo
ATRI
Atrion
N/A
9.18
3.06
Axonics, Inc. stock logo
AXNX
Axonics
N/A
8.16
6.40
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
0.49
7.63
6.69
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
0.97
13.81
12.61
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.11
4.52
3.99

Institutional Ownership

CompanyInstitutional Ownership
Atrion Co. stock logo
ATRI
Atrion
66.19%
Axonics, Inc. stock logo
AXNX
Axonics
99.48%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
N/A
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
95.35%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Atrion Co. stock logo
ATRI
Atrion
22.82%
Axonics, Inc. stock logo
AXNX
Axonics
1.85%
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
3.90%
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
3.40%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Atrion Co. stock logo
ATRI
Atrion
7201.76 million1.36 millionNot Optionable
Axonics, Inc. stock logo
AXNX
Axonics
61051.11 million50.16 millionOptionable
Silk Road Medical, Inc stock logo
SILK
Silk Road Medical
41040.63 million37.91 millionOptionable
Shockwave Medical, Inc. stock logo
SWAV
Shockwave Medical
1,46837.54 million36.27 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
98023.25 million22.67 millionOptionable

Recent News About These Companies

Tactile Systems stock tumbles after Q1 miss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Atrion stock logo

Atrion NASDAQ:ATRI

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmic applications in the United States, Canada, Europe, and internationally. The company's fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. Its cardiovascular products comprise Myocardial Protection System that delivers fluids and medications, and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. The company's ophthalmic products consist of a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. It manufactures products for safe needle and scalpel blade containment; inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Axonics stock logo

Axonics NASDAQ:AXNX

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.

Silk Road Medical stock logo

Silk Road Medical NASDAQ:SILK

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Shockwave Medical stock logo

Shockwave Medical NASDAQ:SWAV

Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$10.35 +0.22 (+2.17%)
Closing price 07/3/2025 03:34 PM Eastern
Extended Trading
$10.26 -0.09 (-0.87%)
As of 07/3/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.